Sight Sciences Inc inventory turnover ratio, the Sight Sciences Inc 's ability to sell and replace its inventory in the first quarter 2025, sequentially increased to
1.76 in the first quarter 2025, yet the ratio remained below the average, as SGHT's market remain challenging.Average inventory processing period, for the Sight Sciences Inc in Mar 31 2025 quarter, has decreased to 207 days, compare to 216 days, in the Dec 31 2024 quarter.
Within
Healthcare sector 219 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2025, to
1182, from total ranking in the fourth quarter 2024 at
1241.
SGHT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Sight Sciences Inc Market Share?
What is Inventory Turnover Ratio?
Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector | Inventory Turnover Ratio | Cost of revenues at quarter ending Mar 31 2025 | Inventories at quarter ending Mar 31 2025 |
Scilex Holding Company | 5.21 | $ 14.233 Millions | $ 3 Millions |
Inotiv Inc | 5.15 | $ 162.822 Millions | $ 32 Millions |
Cryoport inc | 5.09 | $ 118.336 Millions | $ 23 Millions |
Henry Schein Inc | 4.91 | $ 8,665.000 Millions | $ 1,766 Millions |
Integer Holdings Corporation | 4.86 | $ 1,270.000 Millions | $ 261 Millions |
Bristol myers Squibb Company | 4.84 | $ 14,069.000 Millions | $ 2,908 Millions |
Evolus Inc | 4.81 | $ 60.642 Millions | $ 13 Millions |
West Pharmaceutical Services Inc | 4.78 | $ 1,895.000 Millions | $ 397 Millions |
Align Technology inc | 4.73 | $ 1,199.000 Millions | $ 254 Millions |
Steris Plc | 4.67 | $ 3,056.751 Millions | $ 655 Millions |
Ufp Technologies Inc | 4.51 | $ 388.000 Millions | $ 86 Millions |
Envista Holdings Corporation | 4.46 | $ 1,150.000 Millions | $ 258 Millions |
Incyte Corporation | 4.41 | $ 324.300 Millions | $ 73 Millions |
Integrated Biopharma Inc | 4.40 | $ 48.000 Millions | $ 11 Millions |
Adm Tronics Unlimited Inc | 4.31 | $ 1.801 Millions | $ 0 Millions |
Alnylam Pharmaceuticals Inc | 4.24 | $ 322.083 Millions | $ 76 Millions |
Logicmark Inc | 4.19 | $ 3.389 Millions | $ 1 Millions |
Transmedics Group Inc | 4.15 | $ 197.880 Millions | $ 48 Millions |
Koru Medical Systems Inc | 4.07 | $ 12.809 Millions | $ 3 Millions |
Organogenesis Holdings Inc | 4.05 | $ 110.768 Millions | $ 27 Millions |
Precision Optics Corporation Inc | 4.04 | $ 13.996 Millions | $ 3 Millions |
Electromed Inc | 4.04 | $ 13.336 Millions | $ 3 Millions |
Vericel Corporation | 4.02 | $ 65.515 Millions | $ 16 Millions |
Ge Healthcare Technologies Inc | 4.01 | $ 8,267.000 Millions | $ 2,061 Millions |
Mirum Pharmaceuticals Inc | 4.00 | $ 86.831 Millions | $ 22 Millions |
Safe Pro Group Inc | 3.97 | $ 1.386 Millions | $ 0 Millions |
Avanos Medical Inc | 3.94 | $ 593.500 Millions | $ 151 Millions |
Idexx Laboratories Inc | 3.93 | $ 1,522.000 Millions | $ 387 Millions |
Medinotec Inc | 3.89 | $ 4.253 Millions | $ 1 Millions |
Abbvie Inc | 3.87 | $ 16,812.000 Millions | $ 4,344 Millions |